Durability of bioprosthetic aortic valve replacement in patients under the age of 60 years — 1-year follow-up from the prospective INDURE registry

Authors:

Abstract
We report 1-year safety and clinical outcomes in patients 2. The 1-year data from the INSPIRIS RESILIA valve demonstrate good safety and excellent haemodynamic performance as well as an early QoL improvement. clinicaltrials.gov: NCT03666741.
Funding Information
  • Edwards Lifesciences (HVT-I18-331)

This publication has 21 references indexed in Scilit: